drugset
drugset / Trial / NCT03266081

Bupivacaine Epiphora Trial

NCT03266081 ↗

Phase 2 Withdrawn McMaster University
NaSingle-groupOpen-labelTreatment

Summary

The objective of this study is to investigate quantitative improvement in excessive tearing after administration of Bupivacaine, a local anesthetic, into the affected eyelids.

Timeline

Start
2015-04
Primary completion
2022-08-23
Completion
2022-08-23

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 0.75 % Topical

Indications

excessive tearing ptosis